Home/ARTHEx Biotech/Frédéric Legros, PhD
FL

Frédéric Legros, PhD

Executive Chairman & Chief Executive Officer

ARTHEx Biotech

ARTHEx Biotech Pipeline

DrugIndicationPhase
ATX-01 (ArthemiR trial)Myotonic Dystrophy Type 1 (DM1)Phase 1/2